Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 22, 2016
Purpose: Regulation FD Disclosure to furnish an investor presentation (Exhibit 99.1) intended for use in meetings with investors or analysts on August 22, 2016, and subsequently.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the existence of an investor presentation and does not contain audited financial statements or specific financial data points.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The document references an attached presentation (Exhibit 99.1) which may contain such information, but the content of that exhibit is not included in the provided text.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing an investor presentation dated August 2016.
Legal Status of Information: The information in this report and its exhibits is furnished pursuant to Item 7.01 and is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934. It is not subject to the liabilities of that section and will not be incorporated by reference into other filings unless expressly referenced.
Investor Verification Checklist
- Review Exhibit 99.1 (TherapeuticsMD, Inc. presentation dated August 2016) for specific financial data and strategic outlook, as the 8-K text itself contains no numbers.
- Verify that the presentation has not been modified since the filing date of August 22, 2016.
- Confirm the legal standing of the information, noting it is not "filed" for liability purposes under Section 18.